DE3587603T2 - Aus follikularer eierstockflüssigkeit isoliertes inhibin. - Google Patents

Aus follikularer eierstockflüssigkeit isoliertes inhibin.

Info

Publication number
DE3587603T2
DE3587603T2 DE85902422T DE3587603T DE3587603T2 DE 3587603 T2 DE3587603 T2 DE 3587603T2 DE 85902422 T DE85902422 T DE 85902422T DE 3587603 T DE3587603 T DE 3587603T DE 3587603 T2 DE3587603 T2 DE 3587603T2
Authority
DE
Germany
Prior art keywords
inhibin
protein
mammal
composition
eluate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE85902422T
Other languages
German (de)
English (en)
Other versions
DE3587603D1 (de
Inventor
Henry Burger
Kretser David De
John Findlay
Robert Forage
Milton Hearn
David Milne-Robertson
Francis Morgan
Richard Wettenhall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash Medical Centre
St Vincents Institute of Medical Research
Biotech Australia Pty Ltd
Prince Henrys Institute of Medical Research
Original Assignee
Monash Medical Centre
St Vincents Institute of Medical Research
Biotech Australia Pty Ltd
Prince Henrys Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monash Medical Centre, St Vincents Institute of Medical Research, Biotech Australia Pty Ltd, Prince Henrys Institute of Medical Research filed Critical Monash Medical Centre
Application granted granted Critical
Publication of DE3587603D1 publication Critical patent/DE3587603D1/de
Publication of DE3587603T2 publication Critical patent/DE3587603T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Centrifugal Separators (AREA)
  • External Artificial Organs (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
DE85902422T 1984-06-08 1985-06-03 Aus follikularer eierstockflüssigkeit isoliertes inhibin. Expired - Lifetime DE3587603T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPG542784 1984-06-08
AUPH003185 1985-04-04

Publications (2)

Publication Number Publication Date
DE3587603D1 DE3587603D1 (de) 1993-11-04
DE3587603T2 true DE3587603T2 (de) 1994-02-10

Family

ID=25642809

Family Applications (1)

Application Number Title Priority Date Filing Date
DE85902422T Expired - Lifetime DE3587603T2 (de) 1984-06-08 1985-06-03 Aus follikularer eierstockflüssigkeit isoliertes inhibin.

Country Status (10)

Country Link
US (2) US5102807A (enExample)
EP (1) EP0185034B1 (enExample)
JP (2) JP2521707B2 (enExample)
AT (1) ATE95194T1 (enExample)
CA (1) CA1341617C (enExample)
DE (1) DE3587603T2 (enExample)
DK (1) DK171711B1 (enExample)
NO (1) NO176570C (enExample)
NZ (1) NZ212248A (enExample)
WO (1) WO1986000078A1 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
DE3650689T2 (de) * 1985-04-18 1999-04-08 Biotechnology Australia Pty. Ltd., East Roseville, Neussuedwales Rekombinantes inhibin
US5089396A (en) * 1985-10-03 1992-02-18 Genentech, Inc. Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
NZ231899A (en) * 1985-10-03 1991-07-26 Genentech Inc Human or porcine inhibin peptide compositions and dna encoding them
US4798885A (en) * 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
US5215893A (en) * 1985-10-03 1993-06-01 Genentech, Inc. Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom
WO1987005702A1 (en) * 1986-03-13 1987-09-24 Biotechnology Australia Pty. Ltd. Method of assay of inhibin
US5015729A (en) * 1986-06-24 1991-05-14 The Salk Institute For Biological Studies Ovine inhibin
US6150328A (en) * 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
ATE120209T1 (de) * 1987-01-29 1995-04-15 Biotech Australia Pty Ltd Isolierung von einkettigen proteinen mit fsh unter- drückender aktivität aus follikularflüssigkeit.
US5032507A (en) * 1987-11-13 1991-07-16 The Salk Institute For Biological Studies Potentiation of erythropoiesis
ATE118351T1 (de) * 1988-05-31 1995-03-15 Biotech Australia Pty Ltd Wirkung von hormonen.
DE69105114T2 (de) * 1990-01-08 1995-05-04 Genentech Inc Methode zur erhöhung der fruchtbarkeit weiblicher säuger.
DE4000327A1 (de) * 1990-01-08 1991-07-11 Stefan Heiden Arzneimittel zur verbesserung der ovarreaktion und der eizell- und embryonen- produktion bei haussaeugetieren
US5942220A (en) * 1990-03-16 1999-08-24 Chiron Corporation Inhibitor of cytokine activity and applications thereof
DE69233022T2 (de) * 1991-11-04 2004-02-12 Genetics Institute, LLC, Cambridge Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
US20080139474A1 (en) * 1991-11-04 2008-06-12 David Israel Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
US5428011A (en) * 1992-06-16 1995-06-27 Procyon Biopharma, Inc. Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma
KR100227406B1 (ko) 1993-05-12 1999-12-01 브루스 엠. 에이센 Bmp-11 조성물
US6291206B1 (en) * 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
AU689184B2 (en) 1993-12-07 1998-03-26 Genetics Institute, Llc BMP-12, BMP-13 and tendon-inducing compositions thereof
US20030171283A1 (en) * 1994-02-28 2003-09-11 Satterlee Daniel G. Inhibin compositions and methods of enhancing production performance
US5786179A (en) * 1994-02-28 1998-07-28 Agritech Technologies Ltd. Heterologous protein comprising avian alpha-subunit inhibin protein and methods of producing same
US5747659A (en) * 1994-02-28 1998-05-05 Agritech Technologies, Ltd. Fusion gene products encoding avian alpha subunit inhibin protein, or an immunogenic fragment thereof, and a carrier protein
AUPO638897A0 (en) * 1997-04-23 1997-05-22 Monash University Modulation of cell growth and methods relating thereto
AU780982B2 (en) * 1997-04-23 2005-04-28 Monash University Inhibin modulation of cell growth
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
US6727224B1 (en) * 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
EP2286847A1 (en) 1999-10-15 2011-02-23 Genetics Institute, LLC Formulations of hyaluronic acid for delivery of osteogenic proteins
CA2355334A1 (en) * 2000-10-16 2002-04-16 Procyon Biopharma Inc. Pharmaceutical preparations and methods for inhibiting tumors
US20030082233A1 (en) * 2000-12-01 2003-05-01 Lyons Karen M. Method and composition for modulating bone growth
TWI329129B (en) 2001-02-08 2010-08-21 Wyeth Corp Modified and stabilized gdf propeptides and uses thereof
US7226587B2 (en) * 2001-06-01 2007-06-05 Wyeth Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
TWI267378B (en) * 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
US20050026833A1 (en) * 2001-11-08 2005-02-03 Rabbani Shafaat Ahmed PSP-94: use for treatment of hypercalcemia and bone metastasis
WO2003099992A2 (en) * 2002-05-17 2003-12-04 Wyeth Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
AU2003297254A1 (en) * 2002-11-07 2004-06-03 Agritech Technology, Ltd Novel compositions that enhance production performance in avians
ES2282904T3 (es) * 2003-09-12 2007-10-16 Wyeth Barras solidas de fosfato calcico inyectables para el suministro de proteinas osteogenicas.
ES2667013T3 (es) 2010-11-29 2018-05-09 Mote Marine Laboratory, Inc. Determinación de las características sexuales de peces usando hormonas peptídicas
BR102014005376A2 (pt) * 2014-03-07 2016-02-10 Ouro Fino Saúde Animal Ltda antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1007568A (en) * 1973-12-13 1977-03-29 Canada Packers Limited Bovine immunoglobulin isolation process
FR2361912A1 (fr) * 1976-08-19 1978-03-17 Merck & Co Inc Vaccin anti-fecondite a base de membrane pellucide solubilisee
US4409139A (en) * 1981-08-10 1983-10-11 The Salk Institute For Biological Studies Gonadostatin
US4423037A (en) * 1982-05-13 1983-12-27 The General Hospital Corporation Inhibitors of peptide hormone action
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
DE3650689T2 (de) * 1985-04-18 1999-04-08 Biotechnology Australia Pty. Ltd., East Roseville, Neussuedwales Rekombinantes inhibin
US4624944A (en) * 1985-06-14 1986-11-25 The Regents Of The University Of California Human seminal alpha-inhibins
US4740587A (en) * 1985-07-18 1988-04-26 The Salk Institute For Biological Studies Inhibin and method of purifying same
US4798885A (en) * 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom
US4737578A (en) * 1986-02-10 1988-04-12 The Salk Institute For Biological Studies Human inhibin
ATE118351T1 (de) * 1988-05-31 1995-03-15 Biotech Australia Pty Ltd Wirkung von hormonen.

Also Published As

Publication number Publication date
EP0185034A4 (enExample) 1988-01-28
NO860427L (no) 1986-02-06
DK171711B1 (da) 1997-04-01
NO176570C (no) 1995-04-26
NO176570B (no) 1995-01-16
US5102807A (en) 1992-04-07
WO1986000078A1 (en) 1986-01-03
JP2521707B2 (ja) 1996-08-07
NZ212248A (en) 1991-05-28
JP2583030B2 (ja) 1997-02-19
JPS61502399A (ja) 1986-10-23
CA1341617C (en) 2011-06-28
EP0185034B1 (en) 1993-09-29
US5364837A (en) 1994-11-15
DK60586A (da) 1986-02-07
JPH0848636A (ja) 1996-02-20
EP0185034A1 (enExample) 1986-06-25
ATE95194T1 (de) 1993-10-15
DK60586D0 (da) 1986-02-07
DE3587603D1 (de) 1993-11-04

Similar Documents

Publication Publication Date Title
DE3587603T2 (de) Aus follikularer eierstockflüssigkeit isoliertes inhibin.
EP0149468B1 (de) Biologisch wirksame Substanz mit hormonellen Eigenschaften, Verfahren zu ihrer Herstellung und Verwendung von Histonen für medizinische Zwecke
DE69006306T2 (de) Synthetische peptide des konjugates von ubiquitin und histon h2a.
DE3852033T2 (de) Follistatin und verfahren zur reinigung desselben.
DE3650088T2 (de) Inhibin und dessen reinigung.
EP0021152B1 (de) Verfahren zur immunologischen Bestimmung von Basalmembranmaterial, hierfür geeignete Basalmembranfragmente und Verfahren zu deren Herstellung, bzw. Gewinnung
BRADDON Relaxin-dependent adenosine 3′, 5′-monophosphate concentration changes in the mouse pubic symphysis
DE3650689T2 (de) Rekombinantes inhibin
Goldwasser et al. Further purification of sheep plasma erythropoietin
DE60034117T2 (de) Verfahren zur herstelllung von gonadotropin-zusammensetzungen
EP0298210B1 (de) Verfahren zur selektiven immunologischen Bestimmung von intaktem Prokollagen Peptid (Typ III) und Prokollagen (Typ III) in Körperflüssigkeiten und Mittel zu dessen Durchführung
DE2421943A1 (de) Modifizierte polypeptide
DE3853383T2 (de) Isolierung von einkettigen proteinen mit fsh unter- drückender aktivität aus follikularflüssigkeit.
DE69033306T2 (de) Proteinkomplex
DE69316388T2 (de) CRF Bindungsproteine
DE2946458A1 (de) Neues protein pp(pfeil abwaerts)11(pfeil abwaerts)
Lunenfeld et al. Immunology of follicle-stimulating hormone and luteinizing hormone
AU636318B2 (en) Inhibin isolated from ovarian follicular fluid
HENRY A study of the antibodies produced in response to purified preparations of sheep interstitial cell stimulating hormone
DE3879684T2 (de) Von protein ps2 abgeleitete peptide.
Jutisz et al. Further evidence for the existence of several active components in sheep pituitary interstitial cell-stimulating hormone
DE69316911T2 (de) Reine tsh zubereitung, verfahren zur herstellung und ihre anwendung für die herstellung von tsh spürelementen für tsh rezeptor nachweis und in tsh rezeptor testproben
DE3334405A1 (de) Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung
EP0121912A1 (de) Radioimmunverfahren zur Bestimmung von Thymosin-beta-4
DE3236267A1 (de) Verfahren zur herstellung von relaxin und verfahren zur hochreinigung von relaxin

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DIE PATENTINHABER LAUTEN RICHTIG: MONASH UNIVERSITY, CLAYTON, VICTORIA, AU PRINCE HENRY'S INSTITUTE OF MEDICAL RESEARCH, MELBOURNE, AU

8364 No opposition during term of opposition